GBD-09259

N/A

Report date: 2022/12/05 16:11:08

NME

Base Information

Drug NameGBD-09259

Drug Alias NameGBD-09259

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors

TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGossamer Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A